INTRODUCTION
============

The principle of a treatment to reach favorable outcomes in endodontic infection management requires the recognition of the problem and the removal of the etiological factors. The microenvironment of root canal presents excellent conditions to establish microbial growth[@B30].

The success of infected root canal therapy is influenced by discrepancy gradients of microorganisms between the endodontic biofilm and the planktonic suspension[@B11]. The phases for the microbial community to develop a biofilm and colonize the environment may sometimes be unusual, but basically occur with the same sequence of developmental steps: deposition of a conditioning film, adhesion and colonization of planktonic microorganisms in a polymeric matrix, co-adhesion of other organisms, and detachment of biofilm microorganisms into their surroundings[@B08],[@B42].

Reduction of endodontic microbiota has been achieved by a series of antimicrobial strategies that include root canal preparation, irrigating solutions, intracanal dressing, and root canal filling. However, innumerous published articles on endodontic infection control are motive of controversy[@B01],[@B09]-[@B11],[@B16],[@B19],[@B24],[@B26],[@B35],[@B39]. Several studies have been developed with different bacterial biofilm models to test the antimicrobial effectiveness of endodontic medicaments[@B01],[@B09]-[@B11],[@B16],[@B19],[@B24],[@B26],[@B35],[@B39]. Investigations have shown either antimicrobial success[@B09] or failure[@B05],[@B11],[@B30] of intracanal medicaments on bacterial biofilm, as well as the presence of biofilm on the entire external root apex surfaces in teeth with pulp necrosis and radiographically visible periapical lesions[@B26]. The susceptibility of oral bacterial biofilm to antimicrobial agents indicates the need to reproduce *in vivo* conditions where bacteria grow as biofilm on tooth surfaces[@B45].

Evidence-based dentistry involving systematic reviews or meta-analyses has been the ultimate goal to integrate the best available research evidence with clinical experience. In this context, it is important to make a critical analysis of therapeutic protocols for the management of bacterial biofilm. The requirement for its development includes studies in human subjects with definite clinical issues, using a critical longitudinal analysis of published articles. The focus on answering clinical questions can be structured by means of problem, intervention, comparison and outcome.

Uncountable investigations[@B01]-[@B05],[@B07],[@B09],[@B12]-[@B15],[@B18],[@B20],[@B22],[@B23],[@B26],[@B27],[@B31]-[@B34],[@B38],[@B39],[@B44] about the antimicrobial potential of intracanal medicaments on bacterial biofilm have shown contradictory results, but the clinical question on how to eliminate the endodontic bacterial biofilm remains unclear. Spratt, et al.[@B39] (2001) verified the bactericidal effect of 2.25% NaOCl, 0.2% chlorhexidine, 10% iodine or phosphate buffered saline on single-species biofilms *(P. intermedia, P. micros, S. intermedius, F. nucleatum* and *E. faecalis)* derived from a range of root canal isolates. The efficacy of a particular agent was dependent on the nature of the organism in the biofilm and on the contact time. NaOCl was generally the most effective agent followed by iodine. However, the clinical effectiveness of these agents must be evaluated in the light of the complexity of root canal anatomy and polymicrobial nature of root canal infections. Abdullah, et al.[@B01] (2005) analyzed the efficacy of 3% NaOCl, 10% povidone iodine, 0. 2% chlorhexidine, 17% EDTA and calcium hydroxide on a clinical isolate of *E. faecalis* grown as biofilm or planktonic suspension phenotype. The difference in gradients of bacterial killing amongst the biofilm, planktonic suspension or pellet presentation was significant and dependent upon the agent, except for NaOCl and calcium hydroxide, in which no difference could be detected. NaOCl was the most effective agent and achieved 100% killing for all presentations of *E. faecalis* after a 2-min contact time. Estrela, et al.[@B11] (2007) determined the antimicrobial efficacy of ozonated water, gaseous ozone, sodium hypochlorite and chlorhexidine in *E. faecalis* biofilm. The irrigation solutions tested for 20 min were not sufficient to inactivate *E. faecalis*. Nair, et al.[@B30] (2005) suggested the need of non-antibiotic chemomechanical measures to treat teeth with infected and necrotic root canals so as to disrupt the biofilm.

Relevant clinical considerations are yet to be elucidated, such as the efficacy of intracanal medicament on bacterial biofilm, the time necessary for a mature endodontic biofilm to form or the ideal biofilm model to assess antimicrobial endodontic substances. The purpose of this paper is to make a critical analysis of the published research on the antibacterial efficacy of intracanal medicaments on bacterial biofilm.

MATERIAL AND METHODS
====================

Search Strategy
---------------

This work was developed based on an analysis of longitudinal studies from a quantitative systematic review of results of several investigations. English-language articles were\' retrieved from electronic biomedical journal databases and handsearching records. Prospective studies were reviewed with regard to the efficacy of the intracanal medicaments on bacterial biofilm. The following databases were searched on August 1^st^ of 2007: MEDLINE (without filter, from 1966 to August 1^st^ of 2007), EMBASE (without filter, from 1980 to August 1^st^ of 2007), Cochrane Oral Health Group Trials Register and Cochrane Central Register of Controlled Trials (CENTRAL). For the electronic search strategy the terms presented in [Table 1](#t01){ref-type="table"} were used as keywords in several combinations.

###### Keywords used in several combinations for the search strategy

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  apical biofilm or,apical biofilms or,endodontic biofilm or,endodontic biofilms or,biofilm and root canal or,biofilms and root canal or,periapical biofilm or,periapical biofilms or,endodontic bacterial plaque or,endodontics bacterial plaque or,endodontic dental plaque or,endodontics dental plaque or,refractory endodontic plaque or,biofilm and intracanal medicaments or,biofilm and intracanal dressing or.
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Handsearching was conducted by the review of the reference lists of the eligible clinical trials and the review of author\'s personal databases of trial reports in an attempt to identify any other relevant studies.

Study Selection
---------------

The selected articles were identified from titles, abstracts and full-text articles by two independent reviewers, considering the tabulated inclusion and exclusion criteria. Disagreements were resolved by consensus. [Table 2](#t02){ref-type="table"} shows the inclusion and exclusion criteria for selection of the articles.

###### Inclusion and exclusion criteria for selection of the articles

  Inclusion criteria
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *In vivo* studies, in humansRelated to the root canal biofilmRandomized controlled trials (RCT)Related to the efficacy of intracanal medicaments on biofilmEnglish-language articles
  Exclusion criteria
  *In vitro* studiesStudies performed in animalsStudies related only to microbial identificationStudies not related to the efficacy of intracanal medicaments on endodontic biofilmStudies related to the periapical biofilmStudies related to the non-endodontic biofilmStudies only with abstract or with no available abstractLiterature reviewsCase reports

RESULTS
=======

Based on the inclusion and exclusion, 91 articles were selected, of which 17 (18.7%) were literature reviews, 8 (8.8%) referred to *in vivo* studies (7 in humans and 1 in animals), 19 (20.1%) referred to *in vitro* studies \[7 (7.7%) articles of biofilm in membrane filter models and 12 (13.1%) articles on root dentin biofilm models\], 9 (10%) were studies on nonendodontic biofilm, and 33 (36.2%) articles related to other types of study (Figure 1).

None of the 8 articles referring to *in vivo* studies met all inclusion criteria ([Table 3](#t03){ref-type="table"}). [Table 4](#t04){ref-type="table"} describes *in vitro* research articles that were excluded for referring to different bacterial biofilm models, contamination time, root canal cleaning and shaping techniques, and therapeutic efficacy.

###### Excluded in *vivo* research articles

  Author (ref.)                         Number of samples   Exclusion Criteria   Intervention                                      Number of sessions   Observation model                  Outcome
  ------------------------------------- ------------------- -------------------- ------------------------------------------------- -------------------- ---------------------------------- --------------
  Nair, et al. [@B30] (2005)            16                  3                    Root canal preparation + 5.25% NaOCl + 17% EDTA   One-visit            LEM, TEM                           Non efficacy
  Araki, et al. [@B02] (2006)           \-                  3, 4, 5              Er:YAG Laser                                      \-                   SEM                                Efficacy
  Khemaleelakul, et al. [@B22] (2006)   10                  3, 4                 \-                                                \-                   Visual, Fluorescent dye-staining   \-
  Noguchi, et al. [@B31] (2005)         27                  3, 4, 5              \-                                                \-                   Immunohistochemical                \-
  Leonardo, et al.[@B26] (2002)         21                  3, 4, 5              \-                                                \-                   SEM                                \-
  Noiri, et al. [@B32] (2002)           6                   3, 4, 5              \-                                                \-                   SEM                                \-
  Tronstad, et al. [@B44] (1990)        \-                  3, 4, 5              \-                                                \-                   SEM                                \-

LEM -- light electron microscopy, TEM -- transmission electron microscopy, SEM -- scanning electron microscopy. (<http://www.ncbi.nlm.nih.gov/PubMed>)

###### Excluded *in vitro* research articles

  Author                               n     Biofilm model   Contamination time                    Microorganisms                                                                                       Intervention                                                                                         Observation method                                       Outcome
  ------------------------------------ ----- --------------- ------------------------------------- ---------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------------- ----------
  George and Kishen[@B14] (2007)       \-    DC              \-                                    *E. faecalis, A. actinomycetemcomitans*                                                              \-                                                                                                   \-                                                       Efficacy
  Chavez de Paz, et al.[@B05] (2007)   \-    MF              \-                                    *E. faecalis, L paracasei, O. uli, S. anginosas, S. gordini, S. oralis, F. nucleatum*                \-                                                                                                   Fluorescent staining                                     NE
  Garcez, et al.[@B13] (2007)          10    DC              3 days                                *P. mirabilis, P. aeruginosa*                                                                        Photodynamic therapy + laser light or root canal preparation                                         Bioluminescence imaging                                  Efficacy
  Sena, et al.[@B34] (2006)            \-    MF              \-                                    *E. faecatis, S. aureus, C. albicans, P. intermedia, P. gingivalis, P. endodontalys, F. nucleatum*   2.5%, 5.25% NaOCI, 2% CHX gel and liquid                                                             \-                                                       \-
  Soukos, et al.[@B38] (2006)          \-    DC              3 days                                *E. faecalis*                                                                                        Photodynamic therapy                                                                                 \-                                                       NE
  Bergmans, et al.[@B04] (2006)        \-    DC              2 h                                   *E. faecalis, A. naeslundii, S. anginosus*                                                           Nd:YAG Laser                                                                                         CSEM and ESEM                                            NE
  Clegg, et al.[@B07] (2006)           \-    DC              7 days                                \-                                                                                                   6%, 3%, 1% NaOCI, 2% CHX + Biopure MTAD                                                              SEM                                                      Efficacy
  Kishen, et al.[@B23] (2006)          \-    DC              2-, 4-, 6-week intervals or 6 weeks   *E. faecalis*                                                                                        \-                                                                                                   x-ray diffraction, FTIR spectroscopy, SEM, LM and LCSM   \-
  George, et al.[@B15] (2005)          45    DC              21 days                               *E. faecalis*                                                                                        \-                                                                                                   SEM, LCSM and LM                                         \-
  Abdullah, et al.[@B01] (2005)        \-    MF              \-                                    *E. faecatis*                                                                                        Ca(OH)2,0.2% CHX, 17% EDTA 10% povidone iodine and 3%NaOCI                                           \-                                                       Efficacy
  Hems, et al.[@B20] (2005)            \-    MF              48 h                                  *E. faecalis*                                                                                        Ozonated water and ozone gas                                                                         \-                                                       NE
  Gulabivala, et al.[@B18] (2004)      198   DC              48 h                                  *E. faecalis*                                                                                        Neutral anolyte, acidic anolyte, catholyte and catholyte + neutral anolyte (ultrasonicated or not)   \-                                                       NE
  Distel, et al.[@B09] (2002)          46    DC              \-                                    *E. faecalis*                                                                                        Ca(OH)~2~ paste or points                                                                            SEM and LCSM                                             NE
  Seal, et al.[@B33] (2002)            35    DC              48 h                                  *S. intermedius*                                                                                     3% NaOCI or TBO and 35-mW helium-neon low power laser                                                \-                                                       NE
  Lima, et al.[@B27] (2001)            \-    MF              1,3 days                              *E. laecalis*                                                                                        2% CHX or antibiotic-based medications                                                               \-                                                       Efficacy
  Spratt, et al.[@B39] (2001)          \-    MF              15 min or 1 h                         *P. intermedia. P. micros, S. intermedius, F. nucleatum, E. faecalis*                                2.25% NaOCI, 0.2% CHX, 10% iodine                                                                    \-                                                       Efficacy
  Barrieshi, et al.[@B03] (1997)       40    DC              \-                                    *F. nucleatum, P. micros, C. rectus*                                                                 \-                                                                                                   SEM                                                      \-

DC -- dentinal contamination, MF -- membrane filter, LM -- light microscopy, LCSM -- laser confocal scanning microscopy, FTIR -- Fourier transform infrared spectrometry, CSEM -- conventional scanning electron microscopy, ESEM -- environmental scanning electron microscopy, LEM -- light electron microscopy, TEM -- transmission electron microscopy, SEM -- scanning electron microscopy, NE -- No efficacy (<http://www.ncbi.nlm.nih.aov/PubMed>)

No article selected in a preliminary review by handsearching met the inclusion criteria either. The results of the analysis demonstrated inefficacy of intracanal medicaments on bacterial biofilm.

DISCUSSION
==========

Systematic reviews, associated or not to meta-analyses, represent major positions at the evidence pyramid towards a direct decision making, capable to indicate clinical procedures certificated by more trustable arguments. The major difficulty found in the present study was the great deal of available information, and the large number of investigations with agreeing and disagreeing conclusions. Scientifically based evidence that confirms the efficacy of intracanal medicaments on bacterial biofilm involves a profound reflection and discussion, regardless of the limits and caution with the methodology[@B16],[@B17],[@B21],[@B36],[@B43]. Longitudinal studies signalize that there is yet no accurate solution to eliminate or disrupt the root canal bacterial biofilm. However, the results of this critical review confirmed that root canal preparation, with careful disinfection and use of intracanal substances that provide good antimicrobial efficacy, tissue dissolution capacity, and acceptable biocompatibility, will definitely improve the prognosis of the treatment of apical periodontitis[@B25],[@B30].

From a total of 91 articles, 8.8% referred to *in vivo* studies (Figure 1), but no article fulfilled all inclusion criteria ([Table 2](#t02){ref-type="table"})[@B26],[@B30],[@B44], particularly the randomized controlled trial studies.

Interestingly, a recently published study contemplating the clinical aspects about the bacterial biofilm is the only one with high level of evidence. Nair, et al.[@B30] (2005) assessed intracanal microbial status of apical root canal system of mesial roots of human mandibular first molars with primary apical periodontitis immediately after one-visit endodontic treatment. The findings highlight the importance and need for stringently applying non-antibiotic chemomechanical measures in order to disrupt the biofilm and reduce the intraradicular microbial load to the lowest possible level to ensure the most favorable long-term prognosis for treatment of infected root canals. In accordance with this study, other investigations also recovered microorganisms from teeth with endodontic infection after antimicrobial endodontic therapy[@B06],[@B41].

The findings of *in vitro* studies ([Table 4](#t04){ref-type="table"}) show an antimicrobial effectiveness of intracanal medicaments on bacterial biofilm[@B01],[@B39] similarly to *in vivo* evaluations involving the presence of biofilm on all external root apex surfaces in teeth with pulp necrosis with periapical lesions[@B26]. Most studies about endodontic biofilm are *in vitro* experiments. Therefore, care should be taken to avoid inappropriate extrapolation of results, which does not allow a clinical decision for therapeutic protocols in humans. It is mandatory to consider the role and importance of biofilm in endodontics, as well as its definition.

Considerable differences were observed in biofilm models and in the time required for its development ([Tables 3](#t03){ref-type="table"} and [4](#t04){ref-type="table"}). In the present study, it was not possible to obtain an ideal combination of results, considering the high heterogeneity of the adopted clinical protocols. This fact limited the performance of a meta-analysis.

The large number of published papers can bring in its context contradictory conclusions. The variability between the employed methodologies, study selection, publication biases, absence of randomized controlled trial, access to all the information of the published experiments and the own nature of the essays, signalizes for some critical implications towards the equation of the problem.

A clinical question that supports the decision about the antibacterial efficacy of intracanal medicaments on bacterial biofilm cannot be answered using a critical longitudinal analysis of published articles. Various obstacles on the analysis of the pertinent data for the included studies involved methodological data that were hidden and that present a relative degree of importance. Relevant aspects of the studies that met the inclusion criteria were considered, such as the experimental model and sample size, the time lapsed from the initial endodontic treatment until the present moment, the method of identification of the bacteria, the presence of bacteria on the initial samples, the chemical substances used during the root canal disinfection, the time of maintenance of the intracanal dressing prior to obturation, and the efficacy of the medicaments against the tested bacteria. However, the difficulty for comparing these studies was due to differences in the adopted treatment strategies, as follows: standardization of the amount of dentin removal after emptying the root canal; the choice of the preparation technique; tooth type and sample size; characteristics and technique of placement of the test materials; confirmation of complete root canal filling; quality control of the irrigation solutions as well as variations in their concentration; biofilm model; time for microbial colonization; criteria for the detection of the periapical lesion, among others.

Despite all known limitations, studies that are not developed in humans are also relevant because, prior to clearance for human use, biological evaluations of dental materials, initial and secondary tests are required[@B40]. Other aspects that must be critically observed and judiciously analyzed are the biofilm model to test the antimicrobial endodontic medicaments, the biological indicator, and the time necessary for biofilm formation.

Socransky and Haffajee[@B37] (2002) reported that the reason for the existence of a biofilm is that it allows microorganisms to stick to and multiply on surfaces. Thus, attached bacteria (sessile) growing in a biofilm display a wide range of characteristics that provide a number of advantages over single-cell (planktonic) bacteria. A major advantage is the protection that the biofilm provides to colonizing species from microorganisms competing for environmental factors, such as host defense mechanisms, and from potentially toxic substances in the environment, such as lethal chemicals or antibiotics. Biofilms can also facilitate processing and uptake of nutrients, cross-feeding (one species providing nutrients to another), removal of potentially harmful metabolic products (often used by other bacteria) as well as the development of an appropriate physicochemical environment (such as a properly lowering the oxidation reduction potential).

Bacterial biofilm has an open architecture with channels traversing from the biofilm surface. This structure affects the movement of molecules and gradients in key determinants develop. Bacteria growing on a surface display a novel phenotype, one of the consequences being an increased resistance to antimicrobial agents. Resistance can result from restricted inhibitor penetration, slower bacterial growth rates, transfer of resistance genes, suboptimal environmental conditions for inhibitor activity, and the expression of a resistant phenotype[@B29]. Duggan and Sedgley[@B10] tested the hypothesis that the ability of *E. faecalis* to form biofilm is related to the source of the strains. The variations observed in these clinical isolates suggested that biofilm formation might be an important factor when considering the virulence phenotype of endodontic strains in general.

Chávez de Paz, et al.[@B05] (2007) evaluated the possible role of biofilm communities. Changes in the environment, such as calcium hydroxide-related pH increase or the effect of antimicrobials, are capable of triggering genetic cascades that modify the physiological characteristics of bacterial cells. Surface adherence by bacteria to form biofilms is a good example of bacterial adaptation. More information is now available about the existence of polymicrobial biofilm communities on root canal walls coupled with new data showing that the adaptive mechanisms of bacteria in these biofilms are significantly augmented for increased survival. This ecological view on the persisting infection problem in endodontics suggests that the action of individual species in refractory endodontic infections is secondary when compared to the adaptive changes of a polymicrobial biofilm community undergoing physiological and genetic changes in response to changes in the root canal environment.

The invasion of root dentinal tubules by root canal bacteria is a multifactorial event in which a limited number of oral bacterial species have the required properties to participate[@B28]. The penetration of microorganisms in infected root dentin have shown variations considering the experimental model, the biological indicator and the time of incubation employed in the studies ([Table 4](#t04){ref-type="table"}). Distel, et al.[@B09] (2002) presented evidence of *E. faecalis* colonization and biofilm formation in root canals of human teeth. In order to develop new treatments to eradicate *E. faecalis* from persistent root canal infections, the mechanisms through which this microorganism maintains these infections must be understood.

CONCLUSION
==========

For all reasons addressed in this paper, and considering the heterogeneity of guidelines to study antimicrobial strategies for endodontic infections and the high clinical success estimate, adequate disinfection assisted by the intracanal medicaments reduces the bacterial population and favors the prognosis. The antimicrobial efficacy of intracanal medicaments on bacterial biofilm still needs to be confirmed. Further studies are required to offer new guidelines for the treatment protocol of endodontic biofilm.
